Bleakley Financial Group, LLC - GENMAB A/S ownership

GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 228 filers reported holding GENMAB A/S in Q1 2024. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bleakley Financial Group, LLC ownership history of GENMAB A/S
ValueSharesWeighting
Q2 2024$717,110
-20.7%
28,536
-5.6%
0.02%
-19.2%
Q1 2024$904,329
+26.7%
30,235
+34.9%
0.03%
+13.0%
Q4 2023$713,630
-15.6%
22,413
-6.5%
0.02%
-23.3%
Q3 2023$845,563
-9.0%
23,974
-1.9%
0.03%
+3.4%
Q2 2023$929,308
-1.5%
24,449
-2.1%
0.03%
-6.5%
Q1 2023$943,473
+0.5%
24,986
+12.8%
0.03%
-8.8%
Q4 2022$939,09822,1590.03%
Other shareholders
GENMAB A/S shareholders Q1 2024
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 214,848$6,980,0002.38%
Cutter & CO Brokerage, Inc. 119,956$3,897,0001.33%
Hardman Johnston Global Advisors LLC 933,449$30,328,0001.29%
Connective Portfolio Management, LLC 18,000$585,0001.00%
Capricorn Fund Managers Ltd 148,411$4,822,0000.88%
TORRAY INVESTMENT PARTNERS LLC 131,708$4,279,0000.82%
First Light Asset Management, LLC 160,885$5,227,0000.61%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1,857$57,189,0000.60%
Yorktown Management & Research Co Inc 10,100$328,0000.42%
Integrated Investment Consultants, LLC 18,550$602,0000.22%
View complete list of GENMAB A/S shareholders